Increased orbital frontal gray matter volume after cognitive behavioural therapy in paediatric obsessive compulsive disorder

World Journal of Biological Psychiatry

Volumn 14, Issue 4, 2013, Pages 319-331

  Huyser, Chaim ^a,b   Van Den Heuvel, Odile A ^c   Wolters, Lidewij H ^a,b   De Haan, Else ^a,b   Boer, Frits ^a   Veltman, Dick J ^c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b De Bascule   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Child; Cognitive behavioural therapy; Neuroimaging; Obsessive compulsive disorder; Orbital frontal cortex

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BRAIN SIZE; CHILD; CHILD PSYCHIATRY; CINGULATE GYRUS; CLINICAL ARTICLE; COGNITIVE THERAPY; CONTROLLED STUDY; CORPUS CALLOSUM; CORPUS STRIATUM; DISEASE SEVERITY; EXTERNAL CAPSULE; FEMALE; GRAY MATTER; HUMAN; LEFT HEMISPHERE; MALE; NERVE CELL PLASTICITY; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSESSIVE COMPULSIVE DISORDER; ORBITAL CORTEX; PARIETAL CORTEX; SCHOOL CHILD; TREATMENT RESPONSE; VOXEL BASED MORPHOMETRY; WHITE MATTER; YALE BROWN OBSESSIVE COMPULSIVE SCALE;

ADOLESCENT; BRAIN; CASE-CONTROL STUDIES; CHILD; COGNITIVE THERAPY; FEMALE; FRONTAL LOBE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; NERVE FIBERS, MYELINATED; NERVE FIBERS, UNMYELINATED; NEURAL PATHWAYS; OBSESSIVE-COMPULSIVE DISORDER; ORGAN SIZE; YOUNG ADULT;

EID: 84877630214     PISSN: 15622975     EISSN: 18141412     Source Type: Journal    
DOI: 10.3109/15622975.2012.674215     Document Type: Article

References (90)

1. Abramowitz JS, Whiteside SP, Deacon BJ. 2005. The effectiveness of treatment for pediatric obsessive-compulsive disorder: A meta-analysis. Behav Ther 36:55-63. (Pubitemid 43150332)
2. Achenbach TM, Edelbrock CS. 1983. Manual for the child behavior checklist and revised child behavior profi le. Vermont: University of Vermont.
3. American Psychiatric Association. 1994. Diagnostic and statistical manual of mental disorders: DSM IV-4th ed. Washington: American Psychiatric Association.
4. Anholt GE, Kempe P, de Haan E, van Oppen P, Cath DC, Smit JH, van Balkom AJ. 2008. Cognitive versus behavior therapy: processes of change in the treatment of obsessive-compulsive disorder. Psychother Psychosom 77:38-42. (Pubitemid 350261946)
5. Aouizerate B, Guehl D, Cuny E, Rougier A, Bioulac B, Tignol J, Burbaud P. 2004. Pathophysiology of obsessive-compulsive disorder: a necessary link between phenomenology, neuropsychology, imagery and physiology. Prog Neurobiol 72:195-221. (Pubitemid 38591296)
6. Aouizerate B, Cuny E, Bardinet E, Yelnik J, Martin-Guehl C, Rotge JY, et al. 2009. Distinct striatal targets in treating obsessivecompulsive disorder and major depression. J Neurosurg 111: 775-779.
7. Apostolova I, Block S, Buchert R, Osen B, Conradi M, Tabrizian S, et al. 2010. Effects of behavioral therapy or pharmacotherapy on brain glucose metabolism in subjects with obsessive-compulsive disorder as assessed by brain FDG PET. Psychiatry Res 184: 105-116.
8. Ashburner J. 2007. A fast diffeomorphic image registration algorithm. Neuroimage 38:95-113. (Pubitemid 47440133)
9. Ashburner J. 2009. Computational anatomy with the SPM software. Magn Reson Imaging 27:1163-1174.
10. Ashburner J, Friston KJ. 2000. Voxel-based morphometry-the methods. Neuroimage 11:805-821.
11. Baxter LR Jr, Schwartz JM, Bergman KS, Szuba MP, Guze BH, Mazziotta JC, et al. 1992. Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessivecompulsive disorder. Arch Gen Psychiatry 49:681-689.
12. Benazon NR, Moore GJ, Rosenberg DR. 2003. Neurochemical analyses in pediatric obsessive-compulsive disorder in patients treated with cognitive-behavioral therapy. J Am Acad Child Adolesc Psychiatry 42:1279-1285. (Pubitemid 39585987)
13. Bergouignan L, Chupin M, Czechowska Y, Kinkingnehun S, Lemogne C, le BG, et al. 2009. Can voxel based morphometry, manual segmentation and automated segmentation equally detect hippocampal volume differences in acute depression? Neuroimage 45:29-37.
14. Breiter HC, Filipek PA, Kennedy DN, Baer L, Pitcher DA, Olivares MJ, et al. 1994. Retrocallosal white matter abnormalities in patients with obsessive-compulsive disorder. Arch Gen Psychiatry 51:663-664.
15. Brett M, Anton JL, Valabregue R, Poline JB. 2002. Region of interest analysis using an SPM toolbox [abstract]. Presented at the 8th International Conference on Functional Mapping of the Human Brain, June 2-6, 2002, Sendai, Japan.
16. Available on CD-ROM in NeuroImage, Vol 16, No 2.
17. Brody AL, Saxena S, Schwartz JM, Stoessel PW, Maidment K, Phelps ME, Baxter LR Jr. 1998. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder. Psychiatry Res 84:1-6. (Pubitemid 28546878)
18. Burgess PW, Dumontheil I, Gilbert SJ. 2007. The gateway hypothesis of rostral prefrontal cortex (area 10) function. Trends Cogn Sci 11:290-298. (Pubitemid 46962331)
19. Cannistraro PA, Makris N, Howard JD, Wedig MM, Hodge SM, Wilhelm S, et al. 2007. A diffusion tensor imaging study of white matter in obsessive-compulsive disorder. Depress Anxiety 24:440-446. (Pubitemid 47606152)
20. Carmona S, Bassas N, Rovira M, Gispert JD, Soliva JC, Prado M, et al. 2007. Pediatric OCD structural brain defi cits in confl ict monitoring circuits: a voxel-based morphometry study. Neurosci Lett 421:218-223. (Pubitemid 46935359)
21. Cecconi JP, Lopes AC, Duran FL, Santos LC, Hoexter MQ, Gentil AF, et al. 2008. Gamma ventral capsulotomy for treatment of resistant obsessive-compulsive disorder: a structural MRI pilot prospective study. Neurosci Lett 447(2-3): 138-142.
22. Culham JC, Kanwisher NG. 2001. Neuroimaging of cognitive functions in human parietal cortex. Curr Opin Neurobiol 11:157-163. (Pubitemid 32289401)
23. Culham JC, Valyear KF. 2006. Human parietal cortex in action. Curr Opin Neurobiol 16:205-212.
24. Fontenelle LF, Harrison BJ, Yucel M, Pujol J, Fujiwara H, Pantelis C. 2009. Is there evidence of brain white-matter abnormalities in obsessive-compulsive disorder? A narrative review. Top Magn Reson Imaging 20:291-298.
25. Friedlander L, Desrocher M. 2006. Neuroimaging studies of obsessive-compulsive disorder in adults and children. Clin Psychol Rev 26:32-49. (Pubitemid 41803610)
26. Garibotto V, Scifo P, Gorini A, Alonso CR, Brambati S, Bellodi L, Perani D. 2010. Disorganization of anatomical connectivity in obsessive compulsive disorder: a multi-parameter diffusion tensor imaging study in a subpopulation of patients. Neurobiol Dis 37:468-476.
27. Giedd JN, Rapoport JL, Garvey MA, Perlmutter S, Swedo SE. 2000. MRI assessment of children with obsessive-compulsive disorder or tics associated with streptococcal infection. Am J Psychiatry 157:281-283. (Pubitemid 30080914)
28. Gilbert AR, Moore GJ, Keshavan MS, Paulson LA, Narula V, MacMaster FP, et al. 2000. Decrease in thalamic volumes of pediatric patients with obsessive-compulsive disorder who are taking paroxetine. Arch Gen Psychiatry 57:449-456. (Pubitemid 30257259)
29. Gilbert AR, Keshavan MS, Diwadkar V, Nutche J, Macmaster F, Easter PC, et al. 2008. Gray matter differences between pediatric obsessive-compulsive disorder patients and high-risk siblings: a preliminary voxel-based morphometry study. Neurosci Lett 435:45-50.
30. Gilbert SJ, Gonen-Yaacovi G, Benoit RG, Volle E, Burgess PW. 2010. Distinct functional connectivity associated with lateral versus medial rostral prefrontal cortex: a meta-analysis. Neuroimage 53:1359-1367.
31. Gogtay N, Giedd JN, Lusk L, Hayashi KM, Greenstein D, Vaituzis AC, et al. 2004. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA 101:8174-8179. (Pubitemid 38698073)
32. Good CD, Johnsrude IS, Ashburner J, Henson RN, Friston KJ, Frackowiak RS. 2001. A voxel-based morphometric study of ageing in 465 normal adult human brains. Neuroimage 14: 21-36. (Pubitemid 32552740)
33. de Haan E, Wolters LH. 2009. Behandeling van de dwangstoornis bij kinderen en adolescenten, Bedwing je dwang. Houten, The Netherlands: Bohn Stafl eu van Loghum.
34. Huyser C, Veltman DJ, de Haan E, Boer F. 2009. Paediatric obsessive-compulsive disorder, a neurodevelopmental disorder? Evidence from neuroimaging. Neurosci Biobehav Rev 33:818-830.
35. Huyser C, Veltman DJ, Wolters LH, de Haan E, Boer F. 2010a. Functional magnetic resonance imaging during planning before and after cognitive-behavioral therapy in pediatric obsessivecompulsive disorder. J Am Acad Child Adolesc Psychiatry 49:1238-1248.
36. Huyser C, Veltman DJ, Wolters LH, de Haan E, Boer F. 2010b. Fuctional magnetic resonance imaging during planning before and after cognitive behavioral therapy in pediatric obsessive compulsive disorder. J Am Acad Child Adolesc Psychiatry 49: 1238-1248.
37. Jenike MA. 1998. Neurosurgical treatment of obsessive-compulsive disorder. Br J Psychiatry Suppl 35:79-90. (Pubitemid 28368354)
38. Joel D, Doljansky J, Schiller D. 2005. ' Compulsive ' lever pressing in rats is enhanced following lesions to the orbital cortex, but not to the basolateral nucleus of the amygdala or to the dorsal medial prefrontal cortex. Eur J Neurosci 21:2252-2262. (Pubitemid 40695250)
39. Kennedy SH, Konarski JZ, Segal ZV, Lau MA, Bieling PJ, McIntyre RS, Mayberg HS. 2007. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 164:778-788. (Pubitemid 46808533)
40. Klein A, Andersson J, Ardekani BA, Ashburner J, Avants B, Chiang MC, et al. 2009. Evaluation of 14 nonlinear deformation algorithms applied to human brain MRI registration. Neuroimage 46:786-802.
41. Kolada JL, Bland RC, Newman SC. 1994. Epidemiology of psychiatric disorders in Edmonton. Obsessive-compulsive disorder. Acta Psychiatr Scand Suppl 376:24-35.
42. Koprivova J, Horacek J, Tintera J, Prasko J, Raszka M, Ibrahim I, Hoschl C. 2009. Medial frontal and dorsal cortical morphometric abnormalities are related to obsessive-compulsive disorder. Neurosci Lett 464:62-66.
43. Kovacs M. 1985. The Children's Depression, Inventory (CDI). Psychopharmacol Bull 21:995-998. (Pubitemid 16177297)
44. Kringelbach ML, Rolls ET. 2004a. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol 72:341-72. (Pubitemid 38626161)
45. Kringelbach ML, Rolls ET. 2004b. The functional neuroanatomy of the human orbitofrontal cortex: evidence from neuroimaging and neuropsychology. Prog Neurobiol 72: 341-372. (Pubitemid 38626161)
46. Lazaro L, Bargallo N, Castro-Fornieles J, Falcon C, Andres S, Calvo R, Junque C. 2009. Brain changes in children and adolescents with obsessive-compulsive disorder before and after treatment: a voxel-based morphometric MRI study. Psychiatry Res 172:140-146.
47. Macmaster F, Vora A, Easter P, Rix C, Rosenberg D. 2010. Orbital frontal cortex in treatment-naive pediatric obsessive-compulsive disorder. Psychiatry Res 181:97-100.
48. Mak HK, Zhang Z, Yau KK, Zhang L, Chan Q, Chu LW. 2010. Effi cacy of voxel-based morphometry with DARTEL and standard registration as imaging biomarkers in Alzheimer's disease patients and cognitively normal older adults at 3.0 Tesla MR Imaging. J Alzheimers Dis 23:655-664.
49. Marsh R, Gerber AJ, Peterson BS. 2008. Neuroimaging studies of normal brain development and their relevance for understanding childhood neuropsychiatric disorders. J Am Acad Child Adolesc Psychiatry 47:1233-1251.
50. Mataix-Cols D, van den Heuvel OA. 2006. Common and distinct neural correlates of obsessive-compulsive and related disorders. Psychiatr Clin North Am 29:391-410, viii.
51. Mechelli A, Ashburner J. 2005. Voxel-based morphometry of the human brain: methods and applications. Curr Med Imaging Rev 1:1-9.
52. Menzies L, Chamberlain SR, Laird AR, Thelen SM, Sahakian BJ, Bullmore ET. 2008a. Integrating evidence from neuroimaging and neuropsychological studies of obsessive-compulsive disorder: the orbitofronto-striatal model revisited. Neurosci Biobehav Rev 32:525-549. (Pubitemid 351173336)
53. Menzies L, Williams GB, Chamberlain SR, Ooi C, Fineberg N, Suckling J, et al. 2008b. White matter abnormalities in patients with obsessive-compulsive disorder and their fi rst-degree relatives. Am J Psychiatry 165:1308-1315.
54. Mitchell DG. 2011. The nexus between decision making and emotion regulation: a review of convergent neurocognitive substrates. Behav Brain Res 217:215-231.
55. Nakatani E, Nakgawa A, Ohara Y, Goto S, Uozumi N, Iwakiri M, et al. 2003. Effects of behavior therapy on regional cerebral blood fl ow in obsessive-compulsive disorder. Psychiatry Res 124:113-120. (Pubitemid 38366260)
56. Nelson EC, Hanna GL, Hudziak JJ, Botteron KN, Heath AC, Todd RD. 2001. Obsessive-compulsive scale of the child behavior checklist: specifi city, sensitivity, and predictive power. Pediatrics 108:E14.
57. Nishida S, Narumoto J, Sakai Y, Matsuoka T, Nakamae T, Yamada K, et al. 2011. Anterior insular volume is larger in patients with obsessive-compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 35:997-1001.
58. O'Kearney RT, Anstey KJ, von SC. 2006. Behavioural and cognitive behavioural therapy for obsessive compulsive disorder in children and adolescents. Cochrane Database Syst Rev 4: CD004856.
59. Ochsner KN, Gross JJ. 2005. The cognitive control of emotion. Trends Cogn Sci 9:242-249. (Pubitemid 40615112)
60. Perlman SB, Pelphrey KA. 2010. Regulatory brain development: Balancing emotion and cognition. Soc Neurosci 1-10.
61. Polman A, Bouman TK, van Hout WJ, de Jong PJ, den Boer JA. 2010. Processes of change in cognitive-behavioural treatment of obsessive-compulsive disorder: Current status and some future directions. Clin Psychol Psychother 17:1-12.
62. Pujol J, Soriano-Mas C, Alonso P, Cardoner N, Menchon JM, Deus J, Vallejo J. 2004. Mapping structural brain alterations in obsessive-compulsive disorder. Arch Gen Psychiatry 61: 720-730. (Pubitemid 38890807)
63. Radua J, van den Heuvel OA, Surguladze S, Mataix-Cols D. 2010. Meta-analytical comparison of voxel-based morphometry studies in obsessive-compulsive disorder vs other anxiety disorders. Arch Gen Psychiatry 67:701-711.
64. Remijnse PL, van den Heuvel OA, Veltman DJ. 2005. Neuroimaging in obsessive-compulsive disorder. Curr Med Imaging Rev 1:331-335.
65. Ridgway GR, Omar R, Ourselin S, Hill DL, Warren JD, Fox NC. 2009. Issues with threshold masking in voxel-based morphometry of atrophied brains. Neuroimage 44:99-111.
66. Rosenberg DR, Keshavan MS. 1998. A.E. Bennett Research Award. Toward a neurodevelopmental model of of obsessive-compulsive disorder. Biol Psychiatry 43:623-640. (Pubitemid 28222383)
67. Rosenberg DR, Keshavan MS, Dick EL, Bagwell WW, Mac-Master FP, Birmaher B. 1997a. Corpus callosal morphology in treatment-naive pediatric obsessive compulsive disorder. Prog Neuropsychopharmacol Biol Psychiatry 21: 1269-1283. (Pubitemid 28046700)
68. Rosenberg DR, Keshavan MS, O'Hearn KM, Dick EL, Bagwell WW, Seymour AB, et al. 1997b. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Arch Gen Psychiatry 54:824-830. (Pubitemid 27383308)
69. Rosenberg DR, Benazon NR, Gilbert A, Sullivan A, Moore GJ. 2000. Thalamic volume in pediatric obsessive-compulsive disorder patients before and after cognitive behavioral therapy. Biol Psychiatry 48:294-300. (Pubitemid 30645799)
70. Saxena S, Gorbis E, O'Neill J, Baker SK, Mandelkern MA, Maidment KM, et al. 2009. Rapid effects of brief intensive cognitive-behavioral therapy on brain glucose metabolism in obsessive-compulsive disorder. Mol Psychiatry 14:197-205.
71. Scahill L, Riddle MA, Swiggin-Hardin M, Ort SI, King RA, Goodman WK, et al. 1997. Children's Yale-Brown Obsessive Compulsive Scale: reliability and validity. J Am Acad Child Adolesc Psychiatry 36:844-852. (Pubitemid 27250450)
72. Schienle A, Schafer A, Hermann A, Rohrmann S, Vaitl D. 2007. Symptom provocation and reduction in patients suffering from spider phobia: an fMRI study on exposure therapy. Eur Arch Psychiatry Clin Neurosci 257:486-493. (Pubitemid 351208373)
73. Schienle A, Schafer A, Stark R, Vaitl D. 2009. Long-term effects of cognitive behavior therapy on brain activation in spider phobia. Psychiatry Res 172:99-102.
74. Schwartz JM, Stoessel PW, Baxter LR Jr, Martin KM, Phelps ME. 1996. Systematic changes in cerebral glucose metabolic rate after successful behavior modifi cation treatment of obsessivecompulsive disorder. Arch Gen Psychiatry 53:109-113. (Pubitemid 26049387)
75. Silverman WK AA. 1996. The Anxiety Disorders Interview Schedule for Children for DSM-IV: Child and Parent Versions. San Antonio, TX: Psychological Corporation.
76. Sowell ER, Thompson PM, Leonard CM, Welcome SE, Kan E, Toga AW. 2004. Longitudinal mapping of cortical thickness and brain growth in normal children. J Neurosci 24: 8223-8231. (Pubitemid 39280801)
77. Spielberger CD, Edwards CD, Montuori J, Lushene R. 1973. Manual for the state-trait anxiety inventory for children. Palo Alto, CA: Consulting Psychologist Press.
78. Stewart SE, Platko J, Fagerness J, Birns J, Jenike E, Smoller JW, et al. 2007. A genetic family-based association study of OLIG2 in obsessive-compulsive disorder. Arch Gen Psychiatry 64: 209-214.
79. Szeszko PR, MacMillan S, McMeniman M, Chen S, Baribault K, Lim KO, et al. 2004a. Brain structural abnormalities in psychotropic drug-naive pediatric patients with obsessivecompulsive disorder. Am J Psychiatry 161:1049-1056. (Pubitemid 38735991)
80. Szeszko PR, MacMillan S, McMeniman M, Lorch E, Madden R, Ivey J, et al. 2004b. Amygdala volume reductions in pediatric patients with obsessive-compulsive disorder treated with paroxetine: preliminary fi ndings. Neuropsychopharmacology 29: 826-832. (Pubitemid 38402491)
81. Szeszko PR, Ardekani BA, Ashtari M, Malhotra AK, Robinson DG, Bilder RM, Lim KO. 2005. White matter abnormalities in obsessive-compulsive disorder: a diffusion tensor imaging study. Arch Gen Psychiatry 62:782-790. (Pubitemid 41002761)
82. Szeszko PR, Christian C, Macmaster F, Lencz T, Mirza Y, Taormina SP, et al. 2008. Gray matter structural alterations in psychotropic drug-naive pediatric obsessive-compulsive disorder: an optimized voxel-based morphometry study. Am J Psychiatry 165:1299-1307.
83. Tzourio-Mazoyer N, Landeau B, Papathanassiou D, Crivello F, Etard O, Delcroix N, et al. 2002. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage 15:273-289. (Pubitemid 34852226)
84. Wechsler D. 1997. Manual for the Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: The Psychological Corporation.
85. Wechsler D. 2003. Wechsler Intelligence Scale for Children. 4th ed. San Antonio, TX: The Psychological Corporation.
86. Wolters LH, de Haan E, Paauw C. 2008. Bedwing je dwang, werkboek. Houten, The Netherlands: Bohn Stafl eu van Loghum,.
87. Yamanishi T, Nakaaki S, Omori IM, Hashimoto N, Shinagawa Y, Hongo J, et al. 2009. Changes after behavior therapy among responsive and nonresponsive patients with obsessive-compulsive disorder. Psychiatry Res 172:242-250.
88. Yassa MA, Stark CE. 2009. A quantitative evaluation of crossparticipant registration techniques for MRI studies of the medial temporal lobe. Neuroimage 44:319-327.
89. Yoo SY, Jang JH, Shin YW, Kim DJ, Park HJ, Moon WJ, et al. 2007. White matter abnormalities in drug-naive patients with obsessive-compulsive disorder: a diffusion tensor study before and after citalopram treatment. Acta Psychiatr Scand 116: 211-219. (Pubitemid 47106663)
90. Yoo SY, Roh MS, Choi JS, Kang DH, Ha TH, Lee JM, et al. 2008. Voxel-based morphometry study of gray matter abnormalities in obsessive-compulsive disorder. J Korean Med Sci 23: 24-30.